Literature DB >> 23646980

P2X7 receptor-induced death of motor neurons by a peroxynitrite/FAS-dependent pathway.

Mandi Gandelman1, Mark Levy, Patricia Cassina, Luis Barbeito, Joseph S Beckman.   

Abstract

The P2X7 receptor/channel responds to extracellular ATP and is associated with neuronal death and neuroinflammation in spinal cord injury and amyotrophic lateral sclerosis. Whether activation of P2X7 directly causes motor neuron death is unknown. We found that cultured motor neurons isolated from embryonic rat spinal cord express P2X7 and underwent caspase-dependent apoptosis when exposed to exceptionally low concentrations of the P2X7 agonist 2'(3')-O-(4-Benzoylbenzoyl)-ATP. The P2X7 inhibitors BBG, oATP, and KN-62 prevented 2'(3')-O-(4-Benzoylbenzoyl)-ATP-induced motor neuron death. The endogenous P2X7 agonist ATP induced motor neuron death at low concentrations (1-100 μM). High concentrations of ATP (1 mM) paradoxically became protective due to degradation in the culture media to produce adenosine and activate adenosine receptors. P2X7-induced motor neuron death was dependent on neuronal nitric oxide synthase-mediated production of peroxynitrite, p38 activation, and autocrine FAS signaling. Taken together, our results indicate that motor neurons are highly sensitive to P2X7 activation, which triggers apoptosis by activation of the well-established peroxynitrite/FAS death pathway in motor neurons.
© 2013 International Society for Neurochemistry.

Entities:  

Keywords:  CD95; adenosine; amyotrophic lateral sclerosis; motor neuron disease; nitric oxide; purinergic

Mesh:

Substances:

Year:  2013        PMID: 23646980      PMCID: PMC3716845          DOI: 10.1111/jnc.12286

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  37 in total

1.  Strong P2X4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis.

Authors:  Anna Casanovas; Sara Hernández; Olga Tarabal; Jaume Rosselló; Josep E Esquerda
Journal:  J Comp Neurol       Date:  2008-01-01       Impact factor: 3.215

Review 2.  Purinergic signalling and disorders of the central nervous system.

Authors:  Geoffrey Burnstock
Journal:  Nat Rev Drug Discov       Date:  2008-07       Impact factor: 84.694

3.  Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration.

Authors:  Miguel Díaz-Hernández; María Díez-Zaera; Jesús Sánchez-Nogueiro; Rosa Gómez-Villafuertes; Josep M Canals; Jordi Alberch; María Teresa Miras-Portugal; José J Lucas
Journal:  FASEB J       Date:  2009-01-26       Impact factor: 5.191

Review 4.  Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events.

Authors:  Savina Apolloni; Cinzia Montilli; Pamela Finocchi; Susanna Amadio
Journal:  FEBS J       Date:  2008-12-09       Impact factor: 5.542

5.  Block of purinergic P2X(7) receptor is neuroprotective in an animal model of Alzheimer's disease.

Authors:  Jae K Ryu; James G McLarnon
Journal:  Neuroreport       Date:  2008-11-19       Impact factor: 1.837

Review 6.  P2X(7) receptor-mediated reactive oxygen and nitrogen species formation: from receptor to generators.

Authors:  J Hewinson; A B Mackenzie
Journal:  Biochem Soc Trans       Date:  2007-11       Impact factor: 5.407

7.  P2X(7) receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis.

Authors:  Carlos Matute; Iratxe Torre; Fernando Pérez-Cerdá; Alberto Pérez-Samartín; Elena Alberdi; Estibaliz Etxebarria; Amaia M Arranz; Rivka Ravid; Alfredo Rodríguez-Antigüedad; MaríaVictoria Sánchez-Gómez; María Domercq
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

8.  Extracellular ATP mediates necrotic cell swelling in SN4741 dopaminergic neurons through P2X7 receptors.

Authors:  Dong-Jae Jun; Jaeyoon Kim; Sang-Yong Jung; Ran Song; Ji-Hyun Noh; Yong-Soo Park; Sung-Ho Ryu; Joung-Hun Kim; Young-Yun Kong; Jun-Mo Chung; Kyong-Tai Kim
Journal:  J Biol Chem       Date:  2007-10-25       Impact factor: 5.157

9.  ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1beta and IL-18 secretion in an autocrine way.

Authors:  Alessandra Piccini; Sonia Carta; Sara Tassi; Denise Lasiglié; Gianluca Fossati; Anna Rubartelli
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

10.  Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors.

Authors:  Diana L Donnelly-Roberts; Marian T Namovic; Ping Han; Michael F Jarvis
Journal:  Br J Pharmacol       Date:  2009-06-22       Impact factor: 8.739

View more
  19 in total

1.  A Photo-clickable ATP-Mimetic Reveals Nucleotide Interactors in the Membrane Proteome.

Authors:  Mark Jelcic; Ke Wang; King Lam Hui; Xiao-Chuan Cai; Balázs Enyedi; Minkui Luo; Philipp Niethammer
Journal:  Cell Chem Biol       Date:  2020-06-09       Impact factor: 8.116

2.  Ligand-independent activation of the P2X7 receptor by Hsp90 inhibition stimulates motor neuron apoptosis.

Authors:  Amy L Strayer; Cassandra N Dennys-Rivers; Karina C Ricart; Narae Bae; Joseph S Beckman; Maria Clara Franco; Alvaro G Estevez
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-29

Review 3.  Purinergic receptors as potential therapeutic targets in Alzheimer's disease.

Authors:  Lucas T Woods; Deepa Ajit; Jean M Camden; Laurie Erb; Gary A Weisman
Journal:  Neuropharmacology       Date:  2015-10-28       Impact factor: 5.250

Review 4.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

5.  Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75NTR and RAGE Signaling in ALS.

Authors:  Mi Jin Kim; Marcelo R Vargas; Benjamin A Harlan; Kelby M Killoy; Lauren E Ball; Susana Comte-Walters; Monika Gooz; Yasuhiko Yamamoto; Joseph S Beckman; Luis Barbeito; Mariana Pehar
Journal:  Antioxid Redox Signal       Date:  2017-06-26       Impact factor: 8.401

Review 6.  Neuronal P2X7 Receptor: Involvement in Neuronal Physiology and Pathology.

Authors:  M Teresa Miras-Portugal; Álvaro Sebastián-Serrano; Laura de Diego García; Miguel Díaz-Hernández
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

Review 7.  Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis.

Authors:  Mariana Pehar; Benjamin A Harlan; Kelby M Killoy; Marcelo R Vargas
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

8.  P2X7 receptor activation mediates superoxide dismutase 1 (SOD1) release from murine NSC-34 motor neurons.

Authors:  Rachael Bartlett; Diane Ly; Neil R Cashman; Ronald Sluyter; Justin J Yerbury
Journal:  Purinergic Signal       Date:  2022-04-28       Impact factor: 3.765

9.  The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1G93A mice.

Authors:  Diane Ly; Anjila Dongol; Peter Cuthbertson; Thomas V Guy; Nicholas J Geraghty; Reece A Sophocleous; Lucia Sin; Bradley J Turner; Debbie Watson; Justin J Yerbury; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2020-03-13       Impact factor: 3.765

10.  PDE5 inhibitors enhance celecoxib killing in multiple tumor types.

Authors:  Laurence Booth; Jane L Roberts; Nichola Cruickshanks; Seyedmehrad Tavallai; Timothy Webb; Peter Samuel; Adam Conley; Brittany Binion; Harold F Young; Andrew Poklepovic; Sarah Spiegel; Paul Dent
Journal:  J Cell Physiol       Date:  2015-05       Impact factor: 6.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.